全文获取类型
收费全文 | 106篇 |
免费 | 3篇 |
专业分类
儿科学 | 8篇 |
妇产科学 | 2篇 |
基础医学 | 12篇 |
口腔科学 | 2篇 |
临床医学 | 13篇 |
内科学 | 26篇 |
皮肤病学 | 3篇 |
神经病学 | 3篇 |
特种医学 | 1篇 |
外科学 | 1篇 |
综合类 | 1篇 |
预防医学 | 13篇 |
眼科学 | 2篇 |
药学 | 19篇 |
肿瘤学 | 3篇 |
出版年
2021年 | 1篇 |
2020年 | 1篇 |
2019年 | 4篇 |
2018年 | 3篇 |
2016年 | 2篇 |
2015年 | 5篇 |
2014年 | 2篇 |
2013年 | 4篇 |
2012年 | 9篇 |
2011年 | 3篇 |
2010年 | 4篇 |
2009年 | 1篇 |
2008年 | 6篇 |
2007年 | 7篇 |
2006年 | 5篇 |
2005年 | 9篇 |
2004年 | 11篇 |
2003年 | 7篇 |
2002年 | 7篇 |
2001年 | 1篇 |
2000年 | 1篇 |
1999年 | 1篇 |
1997年 | 1篇 |
1996年 | 1篇 |
1994年 | 3篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1989年 | 2篇 |
1984年 | 1篇 |
1978年 | 1篇 |
1973年 | 1篇 |
1971年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有109条查询结果,搜索用时 31 毫秒
81.
Strauss SM Astone JM Munoz-Plaza C Hagan H Des Jarlais D 《Substance use & misuse》2005,40(12):1811-1829
Hepatitis C virus (HCV) infection is highly prevalent among drug users. While there are antiviral medications available to combat the virus, the medication regimen is quite arduous, presenting special issues for drug users. We examined the challenges and benefits of using residential substance user treatment programs as venues for clients to undergo HCV medication regimens. Analyses of qualitative data collected from clients and staff in 2003 at four residential substance user treatment programs in the U.S. indicate that challenges primarily include issues involving the medications' side effects, and both financial and communication concerns. Benefits especially involve clients' feelings that they are being proactive in addressing health issues in an environment that provides much-needed support. Findings illuminate the complex issues involved for both clients and the programs, and some steps that programs can take to better support HCV-infected clients regarding HCV medication concerns. 相似文献
82.
There is a need for greater information about the pharmacologic management of sleep disorders in children. Pharmacologic guidelines must be developed specifically for sleep disorders in children. Ideally, these guidelines should be approved by the Food and Drug Administration for a specific sleep disorder or for the pediatric age range. This approval prevents physicians from being forced to prescribe medications as an "off label" indication. Development of easy-to-swallow, chewable, or liquid forms of these medications would be well received by parents everywhere. When these are not available, instructions for compounding these medications into a suspension by pharmacists are needed. Integration of behavioral and pharmacologic treatments may yield better patient outcomes. This approach requires pediatricians to have a comprehensive understanding of clinical sleep disorders in children. Training programs should play the lead role in enhancing pediatricians' knowledge of the pharmacologic treatment of sleep disorders in children. 相似文献
83.
Strauss SM Falkin GP Vassilev Z Des Jarlais DC Astone J 《Journal of substance abuse treatment》2002,22(2):55-62
Drug treatment programs are a site of opportunity for the delivery of primary and secondary hepatitis C (HCV) prevention services to drug users, a population at great risk for contracting and transmitting the virus. Using data collected from a random nationwide sample (N = 439) of drug treatment programs in the United States, this study examines the extent to which various types of HCV services are provided to their patients. Findings indicate that the majority of drug treatment programs educate at least some of their patients about HCV, and provide some type of support for patients who are infected with the virus. Only 29 of the programs in the sample test all of their patients for HCV, however, and 99 programs test none of them. For the most part, residential treatment programs offer more HCV related services than outpatient drug-free programs. 相似文献
84.
Neha Gupta Aditya N. Sarangi Sunil Dadhich V. K. Dixit Kamal Chetri Amit Goel Rakesh Aggarwal 《Indian journal of gastroenterology》2018,37(1):44-49
Background
Hepatitis E is caused by infection with hepatitis E virus (HEV), which has four well-known genotypes. Genotypes 1 and 2 HEV have been reported from human cases in areas where the disease is highly endemic. By contrast, genotypes 3 and 4 HEV, which primarily infect several animal species worldwide, have been reported mainly from sporadic human cases in non-endemic areas such as Japan and high-income countries of Europe and North America. To determine whether genotype 3/4 HEV cause sporadic disease in India, a disease-endemic area, we determined HEV genotype in a group of patients with such disease.Methods
A part of the HEV open reading frame (ORF) 1 was amplified and sequenced from sera of 74 patients with sporadic acute viral hepatitis E from four cities in India. The sequences were compared with prototype sequences for various HEV genotypes and subgenotypes and analyzed using phylogenetic tools to determine the genotype of the isolates. For 12 specimens, a part of HEV ORF2 was also similarly analyzed.Results
Partial ORF1 sequences of all the 74 isolates belonged to genotype 1 HEV, with 88.2% to 100% nucleotide identity with the prototype genotype 1 isolates. Partial ORF2 sequences for all the 12 isolates also belonged to genotype 1 HEV. On phylogenetic analysis, 71 isolates clustered with prototype genotype 1a HEV; the remaining three isolates were located between subgenotypes 1a and 1c but were closer to the former.Conclusion
Human sporadic acute hepatitis E in India is caused almost exclusively by genotype 1 HEV.85.
86.
87.
Shiela Fallon Friedlander M.D. Yuin C. Chan M.D. Yiong H. Chan Ph.D. Lawrence F. Eichenfield M.D. 《Pediatric dermatology》2013,30(3):316-322
Standard teaching dictates that systemic therapy is required for treatment of onychomycosis. It is unknown whether topical antifungal therapy is effective for pediatric nail infections. This prospective, randomized, double‐blind, vehicle‐controlled study was conducted in the Pediatric Dermatology Research Unit at Rady Children's Hospital to determine whether topical antifungal therapy is efficacious for pediatric onychomycosis. Forty patients ages 2 to 16 years with nonmatrix onychomycosis were randomized 1:3 to ciclopirox lacquer or vehicle lacquer. Ciclopirox lacquer or vehicle was applied daily for 32 weeks, with weekly removal of the lacquer and mechanical trimming. Those with poor response were crossed over to active drug at week 12. Thirty‐seven patients completed the 32‐week study, and follow‐up data were collected 1 year after completion of the study from 24 patients. Mycologic cure, effective treatment, and complete cure were assessed, as well as adverse events and effect on quality of life. Mycologic cure was 70% in the treated group and 20% in the vehicle arm (p = 0.03) at week 12. At end of the study (week 32), 77% of treated patients achieved mycologic cure and 71% effective treatment, compared with 22% of the control group. Ninety‐two percent of those who were cured and followed for 1 year remained clear. Topical antifungal lacquer (ciclopirox) can be an effective option for children with nonmatrix onychomycosis. Pediatric onychomycosis does not always require systemic therapy and responds better to topical therapy than does adult disease. 相似文献
88.
Yanfang P. Zhu Isaac Shamie Jamie C. Lee Cameron J. Nowell Weiqi Peng Shiela Angulo Linh N.N. Le Yushan Liu Huilai Miao Hainan Xiong Cathleen J. Pena Elizabeth Moreno Eric Griffis Stephanie G. Labou Alessandra Franco Lori Broderick Hal M. Hoffman Chisato Shimizu Nathan E. Lewis John T. Kanegaye Adriana H. Tremoulet Jane C. Burns Ben A. Croker the Pediatric Emergency Medicine Kawasaki Disease Research Group Consortium 《The Journal of clinical investigation》2021,131(20)
BACKGROUNDMultisystem inflammatory syndrome in children (MIS-C) is a rare but potentially severe illness that follows exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Kawasaki disease (KD) shares several clinical features with MIS-C, which prompted the use of intravenous immunoglobulin (IVIG), a mainstay therapy for KD. Both diseases share a robust activation of the innate immune system, including the IL-1 signaling pathway, and IL-1 blockade has been used for the treatment of both MIS-C and KD. The mechanism of action of IVIG in these 2 diseases and the cellular source of IL-1β have not been defined.METHODSThe effects of IVIG on peripheral blood leukocyte populations from patients with MIS-C and KD were examined using flow cytometry and mass cytometry (CyTOF) and live-cell imaging.RESULTSCirculating neutrophils were highly activated in patients with KD and MIS-C and were a major source of IL-1β. Following IVIG treatment, activated IL-1β+ neutrophils were reduced in the circulation. In vitro, IVIG was a potent activator of neutrophil cell death via PI3K and NADPH oxidase, but independently of caspase activation.CONCLUSIONSActivated neutrophils expressing IL-1β can be targeted by IVIG, supporting its use in both KD and MIS-C to ameliorate inflammation.FUNDINGPatient Centered Outcomes Research Institute; NIH; American Asthma Foundation; American Heart Association; Novo Nordisk Foundation; NIGMS; American Academy of Allergy, Asthma and Immunology Foundation. 相似文献
89.
Shiela Krystal PhD 《Journal of substance abuse treatment》1989,6(4):223-228
This paper describes additional visualizations intended to foster the integration of the spiritual dimension into the treatment of addiction. An earlier paper described visualizations derived from Jungian principles, aiming particularly at calming, centering, and strengthening the spiritual connection. This paper focusses on work with feelings that arise in recovery. It describes the differing stance towards emotions in psychotherapy and in spiritual disciplines, and how these can be unified using visualizations. 相似文献
90.
3-Hydroxy-3-methylglutaryl-CoA reductase (HMGR) is the first specific enzyme of the isoprenoid pathway, which leads to several
classes of primary and secondary metabolites such as sterols, quinones, carotenoids and gibberellins. The structural gene
of HMG-CoA reductase was isolated from the ascomycetous fungus Gibberella fujikuroi. Additionally, the most conserved region of this gene was also isolated from another plant pathogenic fungus, Sphaceloma manihoticola. Both ascomycetous fungi use the plant hormone gibberellin to induce an elongation of infected host plants, and in the case
of S. manihoticola of plant tumors. Sequence analysis revealed a high degree of similarity between the deduced amino-acid sequences in the C-terminal
catalytic domains of all known HMG-CoA reductases, but the highest degree was found between the sequences of both analysed
ascomycetes. In contrast to Saccharomyces cerevisiae, Ustilago maydis and plants, G. fujikuroi and S. manihoticola possess only a single copy of this gene, although the product of HMGR (mevalonate) is the precursor for essential sterol
and quinone biosynthesis and secondary metabolites such as gibberellins. RNA-blot and hybridization experiments showed that
gene expression is not influenced by either glucose or ammonium excess.
Received: 23 December 1995 / Accepted: 2 August 1996 相似文献